ArticleInternational journal of hematology2018

TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model.

Ayako Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.